StockWatch
·

MANALI PETROCHEMICAL LTD.

BSE: 500268

P/L Snapshot

Q2 FY27 · standalone

vs Q1 FY27·vs Q2 FY26
Revenue
361.81
+51.4%+91.6%
Expenditure
288.83
+73.9%+53.9%
Net Profit
53.47
-3.7%+29604.7%
OPM %
20.22%
-11.68pp+19.84pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
-55.4260.06175.54291.03406.51Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Price Chart
Reports

Manali Petro Q2 FY27: Consol PAT Jumps 250% YoY to ₹63.5 Cr as OPM Expands to ~20%

petrochemicals · propylene glycol · margin expansion

ResultsQ2 FY2706 Nov 20263 minMetals & Mining

Manali Petro Q1: consol PAT +349% YoY, but ~97% is an inventory-swing, not steady growth

petrochemicals · propylene glycol · inventory swing

ResultsQ1 FY2713 Aug 20263 minMetals & Mining
Latest
Quarterly Result6 Nov, 1:57 pm

Manali Petro Q2 FY27: Consol PAT Jumps 250% YoY to ₹63.5 Cr as OPM Expands to ~20%

Manali Petrochemicals' consolidated Q2 FY27 (quarter ended 30-Sep-26) revenue rose 59.5% YoY to ₹395.57 Cr and PAT rose 249.9% YoY to ₹63.50 Cr — adjusted to ~+234% after excluding a ₹0.98 Cr one-off exceptional expense booked in the year-ago quarter — with OPM expanding to ~20.0% from 7.79% and NPM to 15.32% from 6.96%. No analyst consensus or management guidance exists for this quarter (confirmed via search: no formal Street estimates or company outlook on record for Manali Petrochemicals), so the print cannot be benchmarked against external expectations and stands on its own against last year's base. Sequentially, PAT was effectively flat (-1.3% QoQ from ₹64.36 Cr) even as revenue grew 44.0% QoQ, because OPM compressed from Q1 FY27's 30.14% to ~20.0% — propylene glycol/propylene oxide economics are spread-driven rather than volume-driven, so a bigger topline did not carry through to the bottom line this quarter. Cost of materials consumed rose to ₹217.46 Cr (55% of revenue) from ₹168.25 Cr in Q1, outpacing the 44% revenue growth and compressing the spread. Consolidated figures (primary) run ~₹10 Cr ahead of standalone PAT of ₹53.47 Cr; the gap is explained almost entirely by the two overseas subsidiaries under AMCHEM Speciality Chemicals (Singapore), which contributed a combined ₹9.78 Cr PAT this quarter per the auditors' report. Note the comparable base a year ago still included Notedome Limited (UK) and Notedome Europe GmbH, divested in November 2025, so the consolidated perimeter itself has changed YoY. This quarter's disclosed developments were administrative (results approved 6-Nov, insider-trading window closure, a September exchange clarification on a price surge) with no operational catalysts; the open items remain the pending Tamil Nadu leasehold-land renewal (lease expired June 2017) and an ₹11.80 Cr Cyclone Michaung insurance claim still carried as a receivable, both repeated as emphasis-of-matter by the auditors. No management press release was available to cross-check the company's own framing of the quarter.

6 Nov 2026, 01:57 pm

Corporate Events

Board MeetingMANALIPETC
2026
6Nov

Board Meeting

The meeting of the Board of Directors is scheduled to consid…

BSE Filing ↗
Board MeetingMANALIPETC
2026
28Sep

Board Meeting

The Annual General Meeting will be held on 28. 09.

BSE Filing ↗
DividendMANALIPETC
2026
21Sep

Dividend

BSE Filing ↗
DividendMANALIPETC
2026
21Sep

₹0.5 / share

BSE Filing ↗
Board MeetingMANALIPETC
2026
13Aug

Board Meeting

The Board of Directors meeting is scheduled to consider and …

BSE Filing ↗
Board MeetingMANALIPETC
2025
5Feb

Board Meeting

Unaudited Financial Results for the quarter and nine months …

BSE Filing ↗
Board MeetingMANALIPETC
2024
4Nov

Board Meeting

Consider and approve Un-Audited financial results (Standalon…

BSE Filing ↗
Board MeetingMANALIPETC
2024
13May

Board Meeting

Consideration and approval of Audited Financial Results (Sta…

BSE Filing ↗
Board MeetingMANALIPETC
2024
12Feb

Board Meeting

to consider and approve Un-Audited Financial Results (Standa…

BSE Filing ↗
Board MeetingMANALIPETC
2023
7Nov

Board Meeting

Consider and approve Un-Audited Financial Results (Standalon…

BSE Filing ↗
DividendMANALIPETC
2023
25Sep

₹0.75 / share

BSE Filing ↗
Board MeetingMANALIPETC
2023
9Aug

Board Meeting

Consideration and approval of Un-Audited Financial Results (…

BSE Filing ↗